2-hydroxyglutaric aciduria is a rare neurometabolic disorder characterized by the significantly elevated levels of hydroxyglutaric acid in one's urine. It is either autosomal recessive or autosomal dominant.
The signs/symptoms of this condition are consistent with the following:
- Intellectual disability,
- Muscular hypotonia
Mutation in several genes can lead to different types of 2-hydroxyglutaric aciduria. For example, the D2HGDH and L2HGDH genes provide instructions for making enzymes that are found in mitochondria - in which these enzymes break down D-2-hydroxyglutarate and L-2-hydroxyglutarate, respectively, as a part of normal reaction series that generate energy for cell activities. Any mutations occur in either of these genes would interrupt the functional enzymes and allow both 2-hydroxyglutarates to accumulate in cells, which cause 2-hydroxyglutaric aciduria type I. Moreover, it is known that type II for L-2-hydroxyglutaric aciduria and a mixed type for both 2-hydroxyglutarates come from mutations in IDH2 gene and SLC25A1 gene, respectively.
2-hydroxyglutaric aciduria is an organic aciduria, and because of the stereoisomeric property of 2-hydroxyglutarate different variants of this disorder are distinguished:
The L-2 form is more common, severe, and mainly affects the central nervous system. The basal ganglia are affected, and cystic cavitations in the white matter of the brain are common, beginning in infancy. This form is chronic, with early symptoms such as hypotonia, tremors, and epilepsy declining into spongiform leukoencephalopathy, muscular choreodystonia, mental retardation, and psychomotor regression.
It is associated with L2HGDH, which encodes L-2-hydroxyglutarate dehydrogenase. L-2-hydroxyglutarate is produced by promiscuous action of malate dehydrogenase on 2-oxoglutarate, and L-2-hydroxyglutarate dehydrogenase is an example of a metabolite repair enzyme that oxidizes L-2-hydroxyglutarate back to 2-oxoglutarate.
The D2 form is rare, with symptoms including macrocephaly, cardiomyopathy, mental retardation, hypotonia, and cortical blindness. It is caused by recessive mutations in D2HGDH (type I) or by dominant gain-of-function mutations in IDH2 (type II).
Combined D-2- and L-2-hydroxyglutaric aciduria
The combined form is characterized by severe early-onset epileptic encephalopathy and absence of developmental progress. It is caused by recessive mutations in SLC25A1 encoding the mitochondrial citrate carrier.
The treatment of 2-Hydroxyglutaric aciduria is based on seizure control, the prognosis depends on how severe the condition is.
- 2-hydroxyglutarate synthase
- 2-hydroxyglutarate dehydrogenase
- Hydroxyacid-oxoacid transhydrogenase
- Alpha-Hydroxyglutaric acid
- ↑ Reference, Genetics Home. "2-hydroxyglutaric aciduria" (in en). https://ghr.nlm.nih.gov/condition/2-hydroxyglutaric-aciduria#inheritance.
- ↑ "L-2-hydroxyglutaric aciduria | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program" (in en). https://rarediseases.info.nih.gov/diseases/10472/l-2-hydroxyglutaric-aciduria.
- ↑ "2-hydroxyglutaric aciduria: MedlinePlus Genetics" (in en). https://medlineplus.gov/genetics/condition/2-hydroxyglutaric-aciduria/.
- ↑ Kranendijk, Martijn; Struys, Eduard A.; Salomons, Gajja S.; Van der Knaap, Marjo S.; Jakobs, Cornelis (2012). "Progress in understanding 2-hydroxyglutaric acidurias". Journal of Inherited Metabolic Disease 35 (4): 571–587. doi:10.1007/s10545-012-9462-5. ISSN 0141-8955. PMID 22391998.
- ↑ "L-2-hydroxyglutaric aciduria: clinical, neuroimaging, and neuropathological findings". Arch. Neurol. 62 (4): 666–670. 2005. doi:10.1001/archneur.62.4.666. PMID 15824270.
- ↑ "L-2-Hydroxyglutaric aciduria: identification of a mutant gene C14orf160, localized on chromosome 14q22.1". Hum. Mol. Genet. 13 (22): 2803–11. November 2004. doi:10.1093/hmg/ddh300. PMID 15385440.
- ↑ Van Schaftingen, E.; Rzem, R.; Veiga-da-Cunha, M. (2009-04-01). "L: -2-Hydroxyglutaric aciduria, a disorder of metabolite repair". Journal of Inherited Metabolic Disease 32 (2): 135–142. doi:10.1007/s10545-008-1042-3. ISSN 1573-2665. PMID 19020988.
- ↑ "D-2-hydroxyglutaric aciduria". J. Child Neurol. 10 (2): 137–142. 1995. doi:10.1177/088307389501000216. PMID 7782605.
- ↑ "Mutations in the D-2-hydroxyglutarate dehydrogenase gene cause D-2-hydroxyglutaric aciduria". Am J Hum Genet 76 (2): 358–60. Jan 2005. doi:10.1086/427890. PMID 15609246.
- ↑ "IDH2 mutations in patients with D-2-hydroxyglutaric aciduria". Science 330 (6002): 336. 2010. doi:10.1126/science.1192632. PMID 20847235. Bibcode: 2010Sci...330..336K.
- ↑ "Combined D-2- and L-2-hydroxyglutaric aciduria with neonatal onset encephalopathy: a third biochemical variant of 2-hydroxyglutaric aciduria?". Neuropediatrics 31 (3): 137–40. 2000. doi:10.1055/s-2000-7497. PMID 10963100.
- ↑ Nota B (2013). "Deficiency in SLC25A1, Encoding the Mitochondrial Citrate Carrier, Causes Combined D-2- and L-2-Hydroxyglutaric Aciduria.". The American Journal of Human Genetics 92 (4): 627–631. doi:10.1016/j.ajhg.2013.03.009. PMID 23561848.
- ↑ RESERVED, INSERM US14 -- ALL RIGHTS. "Orphanet: D 2 hydroxyglutaric aciduria" (in en). http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Expert=79315.
Original source: https://en.wikipedia.org/wiki/2-Hydroxyglutaric aciduria. Read more